mesothelioma clinic | |||||
新闻 | |||||
Undiagnosed Clinic—Meeting the Needs of Patients With Incidental Findings Pembrolizumab Plus Chemo Receives Priority Review From the FDA for Advanced Pleural Mesothelioma. June 29th 2024. Labs and imaging were ordered ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment